Background: Acute brain injury (ABI) and neurodevelopmental disability (NDD) is common in neonates undergoing CPB, however figures are inconsistent in the current literature and the relationship between ABI and NDD is not well defined.
Methods: 120 neonates that had cardiopulmonary bypass (CPB) between July 2011-December 2014 were identified; 25 Norwood procedures and 95 non-Norwood procedures. Data was retrospectively collected including operative, clinical and neurological reports and 12 month neurodevelopmental assessment using the Bayley Scales of Infant and Toddler Development, Version III (BSID-III).
Results: ABI was detected in 12%, all of which was defined as stroke with 36% of those having additional WMI. ABI was significantly greater in the Norwood group (24% vs. 8%, p = 0.03). Significant predictors of ABI in univariate analysis included operative temperature, use of ECMO, length of stay (LOS) in hospital and LOS in ICU. Variables that remained significant on multivariate analysis included operative temperature and the use of ECMO (p < 0.02). BSID-III assessments were complete in 55% of the cohort with 68% demonstrating NDD in at least one subscale. Rates of NDD were significantly greater in those that had ABI, and in those that underwent the Norwood procedure.
Conclusions: The rate of neonatal ABI is greater than in older patients where the risk is usually quoted at 2%. Neonates undergoing the Norwood procedure are at 3X increased risk of ABI, and ABI is associated with NDD at 12 months of age. Preoperative counselling should address this accordingly. University of Western Australia Background: Preterm birth exposes the immature heart to postnatal life during a critical period of cardiomyocyte growth and maturation. We hypothesised that normal right ventricular cardiac development and maturation is modified by premature exposure to postnatal life.
EARLY POSTNATAL GROWTH OF THE RIGHT VENTRICLE IN LAMBS BORN PRETERM
Method: Lambs were delivered preterm (n = 9) at 128 dGA (term = 150 dGA) and managed postnatally in the Preclinical Intensive Care Research Unit (PICRU) at the University of Western Australia, with postnatal care of the lambs following contemporary clinical management. At 7d postnatal age lambs were euthanised. Age-matched fetal control lambs (n = 6) were delivered at 135d GA and euthanised immediately. Cardiac tissue was randomly and systematically sampled for assessment of cardiac morphology, and stereological methods were utilised to quantify right ventricular cardiomyocyte nuclei number.
Results: Lambs delivered preterm had significantly reduced body weights (P <0.0001) at 135d postconceptional age compared to fetal controls. Preterm lambs also had reduced absolute heart weights (P < 0.05), but when adjusted for body weight there was no significant difference between the groups. The number of cardiomyocyte nuclei in the right ventricle of lamb hearts at 135d postconceptional age was also not significantly affected by preterm birth.
Conclusions: Preterm birth results in reduced growth in the early postnatal period, but does not lead to alterations in the number of cardiomyocyte nuclei in the right ventricle. Future analyses will determine if preterm birth influences right ventricular cardiac maturation. Background: For premature and low birth weight (LBW) babies, Male gender has been associated with poorer outcomes and hence a "male disadvantage" is reported for survival outcomes. Some evidence has been inconsistent with this idea and the association of gender with mortality in this group has not recently been systematically evaluated.
GENDER DIFFERENCE IN SURVIVAL FOR PREMATURE AND LOW BIRTH WEIGHT BABIES: A SYSTEMATIC REVIEW
Method: A systematic review was conducted via Medline and Google Scholar electronic databases for articles published between 1990 and 2016. Studies were included if they presented gender-specific results in mortality or survival outcome for premature or LBW babies. A data extraction table was developed to document data from selected studies.
Results: The systematic review yielded 349 articles and an additional 11 from reference lists with 32 eligible studies reviewed. Of these, 26 studies demonstrated a gender difference in mortality; 14 studies showed greater male mortality whereas 12 studies reported better female survival. No gender difference in survival was reported in 6 studies.
Conclusions: Evidence suggests male gender premature and LBW babies continue to experience higher risk of mortality by discharge. The majority of studies indicated poorer male outcome however a small number of studies maintained a null association between gender and mortality. Background: Systemic lupus erythematous (SLE) is associated with increased risks of maternal and perinatal morbidity, particularly hypertension, fetal growth restriction and stillbirth. The anti-malarial hydroxychloroquine (HCQ) is a commonly used disease modifying agents used in SLE. There are limited data on pregnancy outcomes in women with SLE taking HCQ. Here we report our experience.
Method: Single centre retrospective cohort study of all pregnancies >20 weeks gestation in women with SLE 2001-2015. Data were extracted from a Birthing Outcome System and medical records.
Results: There were 244 pregnancies in 159 women. In 86 (35%) pregnancies the woman had taken HCQ across pregnancy. HCQ use was associated with a significantly lower rate of prednisolone use (38% vs 66%, p < 0.001) and higher rates of use of azathioprine (34% vs 13%, p < 0.001) and aspirin (60% vs 42%, p = 0.007). There were no differences in medical complications of pregnancy. Women taking HCQ were more likely to give birth preterm than those not (37% vs 21%, p = 0.007), mostly because of iatrogenic birth secondary to fetal growth restriction or fetal compromise. The total livebirth rates in women taking HCQ or taking it were similar (98% vs 97%, p = 0.7).
Conclusions: The use of HCQ in pregnancy by women with SLE was, in our centre, associated with less prednisolone use but a higher rate of iatrogenic preterm birth. These observations may direct future care decisions and the design of future prospective studies.
THE ROLE OF TROP2 IN TROPHOBLAST INVASION AND PLACENTAL DEVELOPMENT
Narula S 1,2 , Dimitriadis E
